Friday, July 31, 2026

How Evolus’ Botulinum Toxin Jeuveau and Filler Evolize Drive 500 Million USD Revenue by 2028

Daewoong Pharmaceutical's U.S. partner, Evolus, achieved double-digit revenue growth for six years and turned a profit in Q4.

North Korea Launches New School Year: What Does the 12-Year Compulsory Education Reform Mean for Students?

North Korea's schools held opening ceremonies for the new academic year, emphasizing education and rehabilitation for disabled children.

Political Betting Trends: Why U.S. Users Dominated Polymarket with 570 Million USD in 2026

U.S. users placed $570M in political bets on Polymarket, focusing on geopolitical issues rather than elections, with notable interest in Ukraine.

Tag: Hadlima

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.